Parkinson’s trial aims to detect disease at much earlier stage

Parkinson’s trial aims to detect disease at much earlier stage

Publication date: Mar 14, 2019

Credit: Wikipedia A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson’s, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.

The PREDICT-PD study, funded by Parkinson’s UK, aims to build a much more detailed picture of this early phase, allowing the condition to be detected before it has become firmly established and raising the chance that a successful treatment may be found.

Dr. Alastair Noyce, co-leader of the study at Queen Mary University of London, said: “In recent years we have made much progress in understanding what puts people at higher risk of Parkinson’s.

Professor Anette Schrag (UCL Clinical Neuroscience), co-leader of the study, said: “We believe that if we can predict who is going to get Parkinson’s, we will be able to develop treatments for those in the early stages that could slow or prevent the condition progressing-which would be a major step forwards towards a cure and could have knock-on implications for dementia and other age-related diseases of the brain. “

Dr. Beckie Port, Research Manager at Parkinson’s UK, said: “Studies like PREDICT-PD are critical to making sure we can deliver new and better treatments for everyone with Parkinson’s as fast as possible.

“By taking part in this ambitious study, people who are not living with the condition have the opportunity to help bring forward the day when no one fears Parkinson’s. “

Concepts Keywords
Algorithm Parkinson s algorithm
Alzheimer Alpha
Brain Neuroscience
Clinical Trials Clinical trial
Cognition Articles
Dementia Parkinson’s disease
Fair Dealing Health
Immunohistochemistry S algorithm
London
Neurodegenerative
Neurological
Parkinson
Queen Mary
Questionnaire
Register
Saliva
Sleep
Staining
Stiffness
Stress
Substantia Nigra
Tremor

Semantics

Type Source Name
gene UNIPROT LARGE1
gene UNIPROT SMIM10L2B
gene UNIPROT SMIM10L2A
gene UNIPROT SLC35G1
disease MESH tremor
gene UNIPROT MAGEE1
gene UNIPROT PTPN5
disease MESH dementia
disease DOID dementia
drug DRUGBANK Coenzyme M
gene UNIPROT EGR3
drug DRUGBANK Tropicamide
gene UNIPROT FASTK
gene UNIPROT NR4A2
gene UNIPROT ALG3
disease MESH neurodegenerative disease
disease DOID neurodegenerative disease
gene UNIPROT CEP55

Similar

Leave a Comment

Your email address will not be published. Required fields are marked *